openPR Logo
Press release

Korematsu Institute Publicly Debuts Short Documentary, "Error Before Us" in Honor of 80th Anniversary of Korematsu v. United States on December 18, 2024

12-18-2024 11:04 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

Korematsu Institute Publicly Debuts Short Documentary, "Error

Image: https://www.abnewswire.com/uploads/10e900660feb4a6eb3de47b18918a0e3.png

DECEMBER 18, 2024 - San Francisco, CA - The Fred T. Korematsu Institute is publicly debuting the short film, "Error Before Us: The Coram Nobis Cases", [http://korematsuinstitute.org/] in honor of the anniversary of the landmark Korematsu v. United States Supreme Court case decision on their website.

December 18, 2024, is the 80th anniversary of the Korematsu v. United States civil rights case. With the decision, the Supreme Court upheld the constitutionality of the mass incarceration of Japanese Americans during WWII. The coram nobis cases examine government overreach of power, the lack of due process, and the strength of our Constitution in times of strife.

Woven together with the incarceration of 125,000 Japanese Americans are the broader issues such as the right to due process in the Fifth Amendment, the Equal Protection Clause of the Fourteenth Amendment, and the civil liberties guaranteed to every American citizen. The documentary features interviews with some pivotal members of the legal teams responsible for the cases.

In October 2023, the Fred T. Korematsu Institute commemorated the 40th anniversary of the coram nobis cases of Fred Korematsu, Gordon Hirabayashi, and Minoru Yasui in San Francisco. This film was directed by Eric Fournier and produced for the event.

As we honor the past, we can take action today through civic education and voting to advocate for a future of diversity, equity, and inclusion. For more information or to watch the film, please visit the Fred T. Korematsu Institute website: korematsuinstitute.org [https://korematsuinstitute.org/]

Media Contact
Company Name: Fred T. Korematsu Institute
Contact Person: MIchelle Mitchell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=korematsu-institute-publicly-debuts-short-documentary-error-before-us-in-honor-of-80th-anniversary-of-korematsu-v-united-states-on-december-18-2024]
Country: United States
Website: http://korematsuinstitute.org/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Korematsu Institute Publicly Debuts Short Documentary, "Error Before Us" in Honor of 80th Anniversary of Korematsu v. United States on December 18, 2024 here

News-ID: 3791688 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases